Filana Therapeutics, Inc. (FLNA)
0.9309
-0.03
(-3.53%)
USD |
NASDAQ |
Oct 02, 16:00
0.9506
+0.02
(+2.12%)
After-Hours: 20:00
Filana Therapeutics Net Income (Quarterly) : -8.603M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.603M |
| March 31, 2026 | -10.33M |
| December 31, 2025 | -12.54M |
| September 30, 2025 | -10.81M |
| June 30, 2025 | -44.22M |
| March 31, 2025 | -23.40M |
| December 31, 2024 | -27.60M |
| September 30, 2024 | -27.94M |
| June 30, 2024 | 6.155M |
| March 31, 2024 | 25.04M |
| December 31, 2023 | -20.92M |
| September 30, 2023 | -25.65M |
| June 30, 2023 | -26.38M |
| March 31, 2023 | -24.27M |
| December 31, 2022 | -19.13M |
| September 30, 2022 | -20.26M |
| June 30, 2022 | -19.33M |
| March 31, 2022 | -17.53M |
| December 31, 2021 | -14.17M |
| September 30, 2021 | -9.562M |
| June 30, 2021 | -5.125M |
| March 31, 2021 | -3.526M |
| December 31, 2020 | -2.618M |
| September 30, 2020 | -1.43M |
| June 30, 2020 | -1.136M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.15M |
| December 31, 2019 | -1.516M |
| September 30, 2019 | -0.697M |
| June 30, 2019 | -1.059M |
| March 31, 2019 | -1.359M |
| December 31, 2018 | -0.677M |
| September 30, 2018 | -1.267M |
| June 30, 2018 | -2.452M |
| March 31, 2018 | -2.16M |
| December 31, 2017 | -2.418M |
| September 30, 2017 | -2.59M |
| June 30, 2017 | -4.16M |
| March 31, 2017 | -2.743M |
| December 31, 2016 | -2.522M |
| September 30, 2016 | -3.518M |
| June 30, 2016 | -3.015M |
| March 31, 2016 | -5.795M |
| December 31, 2015 | -4.517M |
| September 30, 2015 | -3.671M |
| June 30, 2015 | -3.374M |
| March 31, 2015 | -2.583M |
| December 31, 2014 | -2.156M |
| September 30, 2014 | -3.534M |
| June 30, 2014 | -3.246M |
| March 31, 2014 | -3.45M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| CorMedix, Inc. | 25.99M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| BioStem Technologies, Inc. | -8.971M |
| Wave Life Sciences, Inc. | -69.36M |
| Axsome Therapeutics, Inc. | -51.31M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.603M |
| EPS Diluted (Quarterly) | -0.1781 |
| Enterprise Value | -37.71M |
| Earnings Yield | -94.03% |
| Normalized Earnings Yield | -94.02 |